Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983;275(2):71-5.
doi: 10.1007/BF00412877.

Profile of anti-stratum corneum autoantibodies in psoriatic patients

Profile of anti-stratum corneum autoantibodies in psoriatic patients

H Tagami et al. Arch Dermatol Res. 1983.

Abstract

Using autologous normal skin and freshly separated sera, the titers of circulating anti-stratum corneum (SC) IgG autoantibodies, which were predominantly demonstrated by ordinary indirect immuno-fluorescence (IF), and those of complement-fixing anti-SC autoantibodies were compared in 16 psoriatic patients with active lesions, 16 patients with nonpsoriatic inflammatory dermatoses, and 11 normal subjects. As in patients with other inflammatory dermatoses, the titers of IgG anti-SC autoantibodies in psoriatic patients were not specifically higher than in normal controls but were more variable, indicating that their circulating levels are dependent on a delicate balance between consumption at inflammatory sites and a secondary increase due to SC-antigen release following inflammation. The titers of complement-fixing anti-SC autoantibodies were much higher than those of IgG autoantibodies in most cases but they were not particularly high in psoriatic patients. From these findings, we think that if these autoantibodies are really involved in complement activation in inducing the transepidermal leukocyte migration of psoriatic lesions, a local factor of psoriatic epidermis, which may facilitate the permeation of these antibodies toward the SC, plays a more important role than the actual circulating antibody levels.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Dermatol Res. 1978 Apr 7;261(2):123-34 - PubMed
    1. Arch Dermatol Forsch. 1974;251(2):95-110 - PubMed
    1. Br J Dermatol. 1977 Jan;96(1):94-5 - PubMed
    1. Arch Dermatol Res. 1979 Feb 23;264(1):65-71 - PubMed
    1. Int Arch Allergy Appl Immunol. 1970;38(1):78-92 - PubMed

Publication types